Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRASG12D-driven Pancreatic Tumorigenesis.

Chuvin N, Vincent DF, Pommier RM, Alcaraz LB, Gout J, Caligaris C, Yacoub K, Cardot V, Roger E, Kaniewski B, Martel S, Cintas C, Goddard-Léon S, Colombe A, Valantin J, Gadot N, Servoz E, Morton J, Goddard I, Couvelard A, Rebours V, Guillermet J, Sansom OJ, Treilleux I, Valcourt U, Sentis S, Dubus P, Bartholin L.

Cell Mol Gastroenterol Hepatol. 2017 May 31;4(2):263-282. doi: 10.1016/j.jcmgh.2017.05.005. eCollection 2017 Sep.


TIF1γ Suppresses Tumor Progression by Regulating Mitotic Checkpoints and Chromosomal Stability.

Pommier RM, Gout J, Vincent DF, Alcaraz LB, Chuvin N, Arfi V, Martel S, Kaniewski B, Devailly G, Fourel G, Bernard P, Moyret-Lalle C, Ansieau S, Puisieux A, Valcourt U, Sentis S, Bartholin L.

Cancer Res. 2015 Oct 15;75(20):4335-50. doi: 10.1158/0008-5472.CAN-14-3426. Epub 2015 Aug 17.


Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β.

Alcaraz LB, Exposito JY, Chuvin N, Pommier RM, Cluzel C, Martel S, Sentis S, Bartholin L, Lethias C, Valcourt U.

J Cell Biol. 2014 May 12;205(3):409-28. doi: 10.1083/jcb.201308031.


Transcriptional repression of estrogen receptor α signaling by SENP2 in breast cancer cells.

Nait Achour T, Sentis S, Teyssier C, Philippat A, Lucas A, Corbo L, Cavaillès V, Jalaguier S.

Mol Endocrinol. 2014 Feb;28(2):183-96. doi: 10.1210/me.2013-1376. Epub 2013 Jan 1.


hCAF1/CNOT7 regulates interferon signalling by targeting STAT1.

Chapat C, Kolytcheff C, Le Romancer M, Auboeuf D, De La Grange P, Chettab K, Sentis S, Corbo L.

EMBO J. 2013 Mar 6;32(5):688-700. doi: 10.1038/emboj.2013.11. Epub 2013 Feb 5.


Cracking the estrogen receptor's posttranslational code in breast tumors.

Le Romancer M, Poulard C, Cohen P, Sentis S, Renoir JM, Corbo L.

Endocr Rev. 2011 Oct;32(5):597-622. doi: 10.1210/er.2010-0016. Epub 2011 Jun 15. Review.


[Post-translational modifications modulate estrogen receptor alpha activity in breast tumors].

Poulard C, Bouchekioua-Bouzaghou K, Sentis S, Corbo L, Le Romancer M.

Med Sci (Paris). 2010 Jun-Jul;26(6-7):636-40. doi: 10.1051/medsci/2010266-7636. Review. French.


Methylation, a key step for nongenomic estrogen signaling in breast tumors.

Le Romancer M, Treilleux I, Bouchekioua-Bouzaghou K, Sentis S, Corbo L.

Steroids. 2010 Aug-Sep;75(8-9):560-4. doi: 10.1016/j.steroids.2010.01.013. Epub 2010 Jan 29. Review.


Protein arginine methylation in estrogen signaling and estrogen-related cancers.

Teyssier C, Le Romancer M, Sentis S, Jalaguier S, Corbo L, Cavaillès V.

Trends Endocrinol Metab. 2010 Mar;21(3):181-9. doi: 10.1016/j.tem.2009.11.002. Epub 2009 Dec 11. Review.


Regulation of estrogen rapid signaling through arginine methylation by PRMT1.

Le Romancer M, Treilleux I, Leconte N, Robin-Lespinasse Y, Sentis S, Bouchekioua-Bouzaghou K, Goddard S, Gobert-Gosse S, Corbo L.

Mol Cell. 2008 Jul 25;31(2):212-21. doi: 10.1016/j.molcel.2008.05.025.


hCAF1, a new regulator of PRMT1-dependent arginine methylation.

Robin-Lespinasse Y, Sentis S, Kolytcheff C, Rostan MC, Corbo L, Le Romancer M.

J Cell Sci. 2007 Feb 15;120(Pt 4):638-47. Epub 2007 Jan 30.


Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.

Sentis S, Le Romancer M, Bianchin C, Rostan MC, Corbo L.

Mol Endocrinol. 2005 Nov;19(11):2671-84. Epub 2005 Jun 16.


Conservation of the deadenylase activity of proteins of the Caf1 family in human.

Bianchin C, Mauxion F, Sentis S, Séraphin B, Corbo L.

RNA. 2005 Apr;11(4):487-94.


BTG2 antiproliferative protein interacts with the human CCR4 complex existing in vivo in three cell-cycle-regulated forms.

Morel AP, Sentis S, Bianchin C, Le Romancer M, Jonard L, Rostan MC, Rimokh R, Corbo L.

J Cell Sci. 2003 Jul 15;116(Pt 14):2929-36. Epub 2003 May 27.

Supplemental Content

Loading ...
Support Center